DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Great Hill Capital LLC

Great Hill Capital LLC raised its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 7.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,749,065 shares of the medical instruments supplier’s stock after buying an additional 126,680 shares during the quarter. DENTSPLY SIRONA comprises approximately 1.0% of Great Hill Capital LLC’s portfolio, making the stock its 10th biggest position. Great Hill Capital LLC’s holdings in DENTSPLY SIRONA were worth $15,497,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. BlackRock Inc. bought a new position in shares of DENTSPLY SIRONA during the second quarter valued at approximately $283,405,000. Southpoint Capital Advisors LP bought a new position in DENTSPLY SIRONA during the 1st quarter valued at approximately $116,000,000. Edmond DE Rothschild Holding S.A. purchased a new position in DENTSPLY SIRONA during the second quarter valued at $47,780,000. Paradigm Capital Management Inc. NY purchased a new position in DENTSPLY SIRONA during the second quarter valued at $39,775,000. Finally, Bank of America Corp DE purchased a new position in DENTSPLY SIRONA during the second quarter valued at $31,001,000. 95.70% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on XRAY shares. BMO Capital Markets dropped their target price on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a report on Thursday, September 17th. Piper Sandler reduced their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Friday, October 9th. Leerink Partners reduced their price target on DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating for the company in a report on Wednesday, October 14th. Barrington Research set a $15.00 price target on DENTSPLY SIRONA in a research report on Monday, August 10th. Finally, Barclays lifted their price target on DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research report on Monday, August 24th. Three investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $12.92.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $8.87 on Wednesday. The firm’s 50-day moving average price is $10.00 and its 200-day moving average price is $10.99. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The company has a market cap of $1.77 billion, a PE ratio of 5.89, a PEG ratio of 1.07 and a beta of 0.87. DENTSPLY SIRONA Inc. has a 52-week low of $8.32 and a 52-week high of $14.76.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.17. The firm had revenue of $898.00 million during the quarter, compared to analysts’ expectations of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm’s quarterly revenue was down 4.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.39 EPS for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.